JAG2 and pancreatic neoplasm: In addition to OSCC, JAG2 is overexpressed in many malignant tumors, including myeloma, (Ghoshal et al., 2009; Houde et al., 2004) pancreatic cancer, (Mullendore et al., 2009) and breast cancer(Xing et al., 2011).